Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

GLP-1 Receptor Agonist Drug Class List

See Plans and Pricing

« Back to Dashboard

Drugs in Drug Class: GLP-1 Receptor Agonist

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sanofi-aventis Us	ADLYXIN	lixisenatide	SOLUTION;SUBCUTANEOUS	208471-001	Jul 27, 2016		RX	Yes	Yes	Start Trial	Start Trial	Y			Start Trial
Sanofi-aventis Us	ADLYXIN	lixisenatide	SOLUTION;SUBCUTANEOUS	208471-002	Jul 27, 2016		RX	Yes	Yes	Start Trial	Start Trial	Y			Start Trial
Sanofi-aventis Us	ADLYXIN	lixisenatide	SOLUTION;SUBCUTANEOUS	208471-001	Jul 27, 2016		RX	Yes	Yes	Start Trial	Start Trial	Y			Start Trial
Sanofi-aventis Us	ADLYXIN	lixisenatide	SOLUTION;SUBCUTANEOUS	208471-001	Jul 27, 2016		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

McKinsey

Johnson and Johnson

Medtronic

AstraZeneca

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.